Published in J Mol Cell Cardiol on February 01, 1985
Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J Virol (1990) 2.68
Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A (1985) 2.67
Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform. Circ Res (2014) 2.47
Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A (1992) 2.38
A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J Virol (1996) 2.29
In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A (1987) 2.05
A chimeric plasmid from cDNA clones of poliovirus and coxsackievirus produces a recombinant virus that is temperature-sensitive. Proc Natl Acad Sci U S A (1986) 1.90
Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev (2006) 1.81
The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region. J Virol (1995) 1.64
Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol (1998) 1.46
Clinical and experimental aspects of viral myocarditis. Clin Microbiol Rev (1989) 1.41
Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol (1995) 1.26
Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol (1996) 1.22
Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest (1998) 1.16
The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. Proc Natl Acad Sci U S A (1998) 1.07
Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera. J Virol (1991) 1.04
The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditis. Antimicrob Agents Chemother (2004) 0.92
Tyrosine phosphorylation events during coxsackievirus B3 replication. J Virol (1997) 0.91
Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis. Am J Pathol (2012) 0.88
Type B coxsackieviruses and their interactions with the innate and adaptive immune systems. Future Microbiol (2010) 0.87
In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease. J Virol (2014) 0.86
Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis. Am J Pathol (2009) 0.81
Interferons in enteroviral heart disease: modulation of cytokine expression and antiviral activity. Med Microbiol Immunol (2003) 0.79
Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis. Virol J (2011) 0.76
Induction of a broad spectrum of inflammation-related genes by Coxsackievirus B3 requires Interleukin-1 signaling. Med Microbiol Immunol (2012) 0.76
Coxsackieviral replication and pathogenicity: lessons from gene modified animal models. Med Microbiol Immunol (2003) 0.75
Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J (1982) 17.98
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature (1993) 3.88
Inhibition of minicircular DNA replication in Escherichia coli 15 by rifampicin. Nat New Biol (1972) 3.10
The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03
Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5' uridine residues are regained during plus-strand RNA synthesis. J Virol (1990) 2.68
Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A (1985) 2.67
Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis. Clin Microbiol Rev (1998) 2.48
Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A (1992) 2.38
Detection and typing of human papillomavirus by e6 nested multiplex PCR. J Clin Microbiol (2004) 2.34
An atypical variant of Fabry's disease with manifestations confined to the myocardium. N Engl J Med (1991) 2.27
Isolation and characterization of a ribonuclease 3 deficient mutant of Escherichia coli. Mol Gen Genet (1973) 2.19
Cloning of cDNA of major antigen of foot and mouth disease virus and expression in E. coli. Nature (1981) 2.14
In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A (1987) 2.05
The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene (1988) 2.02
Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell (1983) 1.87
High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation (2005) 1.84
Liposomes as gene carriers: efficient transformation of mouse L cells by thymidine kinase gene. Science (1982) 1.78
Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia (2004) 1.71
The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature (1990) 1.69
Uber infektiöse Substrukturen aus Escherichia coli Bakteriophagen. VII. Formation of a biologically intact replicative form in ribonucleic acid bacteriophage (M12)-infected cells. J Mol Biol (1966) 1.63
Appearance of beta-lactamase activity in animal cells upon liposome-mediated gene transfer. Gene (1980) 1.63
Infectious nucleic acids of e. Coli bacteriophages, ix. Sedimentation constants and strand integrity of infectious m12 phage replicative-form RNA. Proc Natl Acad Sci U S A (1966) 1.58
Diversity of surface layers in L-forms of Proteus mirabilis. J Gen Microbiol (1968) 1.57
A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene (1988) 1.54
Translation of avian myeloblastosis virus RNA in a cell-free lysate of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.53
Myosin light chain-2 luciferase transgenic mice reveal distinct regulatory programs for cardiac and skeletal muscle-specific expression of a single contractile protein gene. J Biol Chem (1992) 1.49
Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci U S A (1992) 1.47
Purification, renaturation, and reconstituted protein kinase activity of the Sendai virus large (L) protein: L protein phosphorylates the NP and P proteins in vitro. J Virol (1990) 1.46
Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J (1992) 1.43
[Isolated myocardial noncompaction in childhood-case report and review of the literature]. Z Kardiol (2003) 1.40
Infectious nucleic acids of Escherichia coli bacteriophages. 10. Preparation and properties of Escherichia coli competent for infectious DNA from bacteriophages phi X 174 and M 13 and RNA from bacteriophage M 12. Eur J Biochem (1967) 1.37
Direct myocardial injury by enterovirus: a central role in the evolution of murine myocarditis. Clin Immunol Immunopathol (1993) 1.32
The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology (1996) 1.32
Cardioselective infection with coxsackievirus B3 requires intact type I interferon signaling: implications for mortality and early viral replication. Circulation (2001) 1.31
Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene (1995) 1.29
Large-scale preparations of viruses by steric chromatography on columns of controlled pore glass. Phi-X174, M13, M12, Q-beta and T4 bacteriophages. Biochim Biophys Acta (1969) 1.29
h-sgk serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology (1999) 1.28
A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci U S A (1990) 1.27
Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J Gen Virol (1981) 1.26
Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol (1995) 1.26
Human papillomavirus type 16-associated primary squamous cell carcinoma of the rectum. Gastroenterology (2001) 1.26
Mutant of phi X174 accessible to host-controlled modification. J Virol (1969) 1.25
Sendai virus gene expression in lytically and persistently infected cells. Virology (1990) 1.24
Gene order of RNA bacteriophage M 12. Nature (1970) 1.24
Coronary vasospasm as the underlying cause for chest pain in patients with PVB19 myocarditis. Heart (2008) 1.24
Deoxyribonucleic acid-envelope complexes isolated from Escherichia coli by free-flow electrophoresis: biochemical and electron microscope characterization. J Bacteriol (1974) 1.24
Pathogenesis of murine enterovirus myocarditis: virus dissemination and immune cell targets. J Virol (1996) 1.22
Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am J Pathol (1996) 1.21
Expression of hepatitis B surface antigen in unselected cell culture transfected with recircularized HBV DNA. EMBO J (1982) 1.21
Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci U S A (2000) 1.20
Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3. Virus Res (1992) 1.19
A search for the presence of the enteroviral capsid protein VP1 in pancreases of patients with type 1 (insulin-dependent) diabetes and pancreases and hearts of infants who died of coxsackieviral myocarditis. Diabetologia (1990) 1.17
Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology (1995) 1.17
Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. J Clin Invest (1998) 1.16
Biologically active protease of foot and mouth disease virus is expressed from cloned viral cDNA in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.16
An RNA-dependent DNA polymerase, different from the known viral reverse transcriptases, in the chicken system. Proc Natl Acad Sci U S A (1976) 1.15
Viral heart disease. Springer Semin Immunopathol (1989) 1.13
Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis. Circulation (1999) 1.12
Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1. Virology (2000) 1.11
Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J Virol (1996) 1.11
The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs. Virology (1996) 1.11
Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. Circulation (1998) 1.10
Detection of human papillomavirus type 16 E6/E7 oncogene transcripts in dysplastic and nondysplastic cervical scrapes by nested RT-PCR. Gynecol Oncol (1998) 1.10
Secondary structure of RNA phage M12 replicative intermediates in vivo. Biochim Biophys Acta (1973) 1.10
Enhanced production of hepatitis B surface antigen in NIH 3T3 mouse fibroblasts by using extrachromosomally replicating bovine papillomavirus vector. Mol Cell Biol (1983) 1.09
Lysis inhibition of phi-X174-, M12-, and Q-beta-infected Escherichia coli bacteria by magnesium ions. Biochim Biophys Acta (1969) 1.08
Interference of bacteriophage T4 in the reproduction of RNA-phage M12. J Mol Biol (1967) 1.07
Cleavage of RasGAP and phosphorylation of mitogen-activated protein kinase in the course of coxsackievirus B3 replication. J Virol (1999) 1.07
Regulation of intestinal phosphate cotransporter NaPi IIb by ubiquitin ligase Nedd4-2 and by serum- and glucocorticoid-dependent kinase 1. Am J Physiol Gastrointest Liver Physiol (2004) 1.07
Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol Cell Probes (1991) 1.07
Amplification and rearrangement in hepatoma cell DNA associated with integrated hepatitis B virus DNA. EMBO J (1984) 1.06
The genetic organization of integrated hepatitis B virus DNA in the human hepatoma cell line PLC/PRF/5. Nucleic Acids Res (1984) 1.06
Detection of parvovirus in a patient with "reactive arthritis" by in situ hybridization. Clin Rheumatol (1989) 1.06
Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene (1994) 1.06
Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. Carcinogenesis (2003) 1.05
Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera. DNA (1988) 1.05
Membrane attachment of replicating parental DNA molecules of bacteriophage M13. Biochem Biophys Res Commun (1971) 1.05
Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera. J Virol (1991) 1.04
Replication of bacteriophage M 13: inhibition of single-strand DNA synthesis by rifampicin. Proc Natl Acad Sci U S A (1972) 1.03
Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5'-nontranslated region does not contain major attenuation determinants. J Med Virol (1993) 1.02
Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator. Oncogene (1995) 1.02
Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis. Cell Physiol Biochem (2001) 1.00
Visualization of enteroviral replication in myocardial tissue by ultrastructural in situ hybridization: identification of target cells and cytopathic effects. Lab Invest (1998) 0.99
Recombinant retroviral DNA yielding high expression of hepatitis B surface antigen. EMBO J (1982) 0.99
Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro. Oncogene (1996) 0.99
The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Res (1998) 0.99
Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells. J Infect Dis (1992) 0.99
Isolation and molecular characterization of hepatitis B virus X-protein from a baculovirus expression system. Hepatology (1997) 0.99
Shock wave permeabilization as a new gene transfer method. Gene Ther (1997) 0.98
Direct evidence for messenger activity of influenza virion RNA. Proc Natl Acad Sci U S A (1973) 0.97
Replication of the single stranded DNA bacteriophage M 13. Intracellular flow of parental DNA and transfer to progeny particles. Eur J Biochem (1970) 0.96